Skip Navigation



NDT Advance Access published online on February 5, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp021
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/7/2240    most recent
gfp021v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schiller, B.
Right arrow Articles by Moran, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiller, B.
Right arrow Articles by Moran, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


False low parathyroid hormone values secondary to sample contamination with the tissue plasminogen activator

Brigitte Schiller1,2, Amy Wong1, Marty Blair1 and John Moran2

1 Satellite Laboratory Services, Redwood City 2 Satellite Healthcare, Mountain View, CA, USA

Correspondence and offprint requests to: Brigitte Schiller, Clinical Director, Satellite Laboratory Services, 1400 Industrial Way, Redwood City, CA 94063, USA. Tel: +1-650-404-3640; Fax: +1-650-625-6240; E-mail: schillerb{at}satellitehealth.com



  Abstract

Background. Fluctuating parathyroid hormone values (PTH) are common in patients undergoing haemodialysis. Widely varying PTH results in an 82-year-old haemodialysis (HD) patient could not be explained. When PTH in the same blood sample was no longer detectable 24 h after blood draw, it was hypothesized that contamination with the catheter lock solution containing tissue plasminogen activator (tPA, alteplase) caused degradation of PTH in vitro.

Methods. Leftover samples from 21 patients on maintenance HD as well as control samples from healthy volunteers (n = 3) were incubated at 4°C with small amounts of tPA (25 and 50 µL). In addition, pooled samples from HD patients with various PTH levels were incubated with 6.5, 12.5 and 25 µL of tPA and analysed with two different PTH assays with incubation times up to 48 h.

Results. A rapid decline of PTH values to 2.5–33.5% of the original baseline was observed after 24 h with a further decrease to <1–15% after 48 h. The two different assays gave very similar results when the samples were incubated with tPA.

Conclusion. Minimal contamination of a blood sample with tPA results in degradation of PTH in a time-dependent manner. The tPA is therefore unique as a contaminant since its enzymatic activity means that even tiny amounts of contamination will lead to major errors in PTH results by digestion of the protein. This phenomenon was independent of the assay used. Strict attention to the technique when drawing a blood sample from a catheter is mandatory to prevent contamination and avoid spurious test results.

Keywords: haemodialysis; haemodialysis access; parathyroid hormone (PTH); tissue plasminogen activator (tPA)

Received for publication: 17. 8.08
Accepted in revised form: 9. 1.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.